RU2013156864A - Способ получения дейтерированных соединений, содержащих n-алкильные группы - Google Patents

Способ получения дейтерированных соединений, содержащих n-алкильные группы Download PDF

Info

Publication number
RU2013156864A
RU2013156864A RU2013156864/04A RU2013156864A RU2013156864A RU 2013156864 A RU2013156864 A RU 2013156864A RU 2013156864/04 A RU2013156864/04 A RU 2013156864/04A RU 2013156864 A RU2013156864 A RU 2013156864A RU 2013156864 A RU2013156864 A RU 2013156864A
Authority
RU
Russia
Prior art keywords
alkyl
phenyl
alkylene
bond
optionally substituted
Prior art date
Application number
RU2013156864/04A
Other languages
English (en)
Russian (ru)
Inventor
Йенс АТЦРОДТ
Фолькер ДЕРДАУ
Вольфганг ХОЛЛА
Маттиас БЕЛЛЕР
Лоренц НОЙБЕРТ
Дирк МИХАЛИК
Original Assignee
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи filed Critical Санофи
Publication of RU2013156864A publication Critical patent/RU2013156864A/ru

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46—Ruthenium, rhodium, osmium or iridium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/07—Monoamines containing one, two or three alkyl groups, each having the same number of carbon atoms in excess of three
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/08—Monoamines containing alkyl groups having a different number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
RU2013156864/04A 2011-05-23 2012-05-21 Способ получения дейтерированных соединений, содержащих n-алкильные группы RU2013156864A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11305634 2011-05-23
EP11305634.5 2011-05-23
PCT/EP2012/059344 WO2012160015A1 (en) 2011-05-23 2012-05-21 Process for the preparation of deuterated compounds containing n-alkyl groups

Publications (1)

Publication Number Publication Date
RU2013156864A true RU2013156864A (ru) 2015-06-27

Family

ID=46146876

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013156864/04A RU2013156864A (ru) 2011-05-23 2012-05-21 Способ получения дейтерированных соединений, содержащих n-алкильные группы

Country Status (10)

Country Link
US (1) US9340489B2 (enExample)
EP (1) EP2714624B1 (enExample)
JP (1) JP5925301B2 (enExample)
KR (1) KR20140030267A (enExample)
CN (1) CN103702961A (enExample)
CA (1) CA2834920A1 (enExample)
IL (1) IL229037A0 (enExample)
RU (1) RU2013156864A (enExample)
SG (1) SG194625A1 (enExample)
WO (1) WO2012160015A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015188073A1 (en) 2014-06-06 2015-12-10 Research Triangle Institute Apelin receptor (apj) agonists and uses thereof
IL308138A (en) * 2014-11-10 2023-12-01 Evrys Bio Llc Preparations against human cytomegalovirus and methods of treating it
AU2016366310C1 (en) 2015-12-09 2021-09-09 Research Triangle Institute Improved apelin receptor (APJ) agonists and uses thereof
AU2017325870B2 (en) 2016-09-16 2021-07-22 Research Traingle Institute Tetrahydroisoquinoline kappa opioid antagonists
ES3032633T3 (en) 2016-10-12 2025-07-22 Res Triangle Inst Heterocyclic apelin receptor (apj) agonists and uses thereof
JOP20190072A1 (ar) 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم
EP3558996A4 (en) 2016-12-21 2020-08-05 Research Triangle Institute, International DIARYLPURINE DERIVATIVES WITH ENHANCED BIOAVAILABILITY
US10494316B2 (en) 2017-04-27 2019-12-03 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from D2O
AU2018260728B2 (en) * 2017-04-27 2022-07-21 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from D2
AU2018346597B2 (en) 2017-10-06 2023-07-13 Forma Therapeutics, Inc. Inhibiting Ubiquitin Specific Peptidase 30
CN109748767A (zh) * 2017-11-07 2019-05-14 朱允涛 一种利用微波反应装置制备氘代胺类化合物的方法
IL278291B2 (en) 2018-05-17 2023-10-01 Forma Therapeutics Inc Condensed bicyclic compounds are useful as ubiquitin-specific peptidase 30 inhibitors
BR112021003189A2 (pt) 2018-08-20 2021-05-11 Duke University métodos e composições de fármacos para tratar doenças oftálmicas
EP4218934B1 (en) 2018-10-05 2025-06-18 Forma Therapeutics, Inc. Inhibiting ubiquitin-specific protease 30 (usp30)
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
MX2021007437A (es) * 2018-12-21 2021-09-08 Terran Biosciences Inc Formas deuteradas y derivados de volinanserina.
KR20220054391A (ko) 2019-08-29 2022-05-02 리서치 트라이앵글 인스티튜트 아펠린 수용체 작용제에 대한 방법 및 용도
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
MX2023007793A (es) 2020-12-30 2023-09-22 Tyra Biosciences Inc Compuestos de indazol como inhibidores de cinasas.
JP2024507574A (ja) 2021-02-25 2024-02-20 リサーチ トライアングル インスティテュート アペリン受容体アゴニストとしてのヘテロアリール誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
WO1991018602A1 (en) 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
KR100477070B1 (ko) * 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
CA2438318A1 (en) 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
TW200413274A (en) * 2002-12-27 2004-08-01 Wako Pure Chem Ind Ltd Deuteration or tritiation method
CA2553376A1 (en) * 2004-01-23 2005-08-04 Wako Pure Chemical Industries, Ltd. Method of deuteration using mixed catalyst
CA2701638A1 (en) * 2007-04-02 2008-10-09 Concert Pharmaceuticals Inc. Pharmaceutical calcimimetics
WO2009005069A1 (ja) * 2007-07-05 2009-01-08 Wako Pure Chemical Industries, Ltd. ルテニウム触媒を用いた重水素化方法
US20100143287A1 (en) * 2008-12-09 2010-06-10 Auspex Pharmaceuticals, Inc. Trifluoromethylphenyl modulators of calcium-sensing receptor

Also Published As

Publication number Publication date
EP2714624B1 (en) 2017-12-27
US9340489B2 (en) 2016-05-17
SG194625A1 (en) 2013-12-30
KR20140030267A (ko) 2014-03-11
US20140081019A1 (en) 2014-03-20
IL229037A0 (en) 2013-12-31
EP2714624A1 (en) 2014-04-09
CA2834920A1 (en) 2012-11-29
JP2014524888A (ja) 2014-09-25
WO2012160015A1 (en) 2012-11-29
CN103702961A (zh) 2014-04-02
JP5925301B2 (ja) 2016-05-25

Similar Documents

Publication Publication Date Title
RU2417993C2 (ru) Замещенные 2-хинолилоксазолы, пригодные в качестве ингибиторов фдэ4
RU2009128591A (ru) Лиганды для визуализации иннервации сердца
RU2011129335A (ru) Способ применения циклических карбодиимидов
DOP2010000230A (es) Derivados de urea de tetrahidroquinoxalina, su preparacion y su aplicacion en terapeutica
RU2018131134A (ru) ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ КАК ИНГИБИТОРЫ ТРК КИНАЗЫ
AR069804A1 (es) Agonistas del receptor glucocorticoide c20- c21 sustituido
CO6321130A2 (es) Piridinas carboxamidas como inhibidores de la 11 beta-hsd1
RU2017134289A (ru) Силаны и отверждаемые композиции, которые содержат эти силаны в качестве сшивающих агентов
AR082029A1 (es) Derivados de heterociclos nitrogenados, composiciones y metodos para modular la via de señalizacion de wnt
RU2012140454A (ru) Способ синтеза соединений диарилтиогидантоина и диарилгидантоина
CO6241101A2 (es) Derivados de quinolina como inhibidores de la p13 quinasa
NI201200051A (es) Nuevos maitansinoides y el uso de dichos maitansonoides para preparar conjugados con un anticuerpo.
AR075177A1 (es) Derivados de tiadiazoles y oxadiazoles, metodo de preparacion, intermediarios de sintesis, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad y diabetes, entre otros.
RU2011106375A (ru) Замещенные хиноксалинового типа мостиковые пиперидиновые соединения и их применение
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
RU2020108470A (ru) Аддитивная композиция для культуральной среды, аддитивное соединение для культуральной среды и способ культивирования клеток или тканей с использованием этой композиции и соединения
AR044715A1 (es) Compuestos tipo amidas que inhiben la reabsorcion de las monoaminas
NI201000049A (es) Método para producir 2'-desoxi-5-azacitidina (decitabina)
RU2013125326A (ru) Гетероциклические соединения в качестве зондов для визуализации tau-патологии
EA201170900A1 (ru) Производные 2-пиридин-2-ил-пиразол-3(2h)-она, их получение и применение в терапии
CO5690593A2 (es) Nuevos derivados de pirimidin 2-amina
CO5690582A2 (es) Derivados de n-tiazol-2-il-benzamida
RU2014129937A (ru) Способы и промежуточные соединения для получения фармацевтических агентов
EA201170899A1 (ru) Производные 2-пиридин-2-ил-пиразол-3(2h)-она, их получение и применение в терапии в качестве активаторов hif
RU2014124531A (ru) (1r,4r) 7-оксо-2-азабицикло[2.2.2]окт-5-ен и его производные

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20150522